Mintz Advises Quantum-SI in $1.46 Billion SPAC Merger
Mintz is acting as legal advisor to Quantum-SI Incorporated, a pioneer in next generation semiconductor chip-based proteomics, in its proposed business combination, valued at $1.46 billion, with HighCape Capital Acquisition Corp. (Nasdaq: CAPA), a healthcare-focused special purpose acquisition company (SPAC) sponsored by growth equity investment firm HighCape Capital LP. Upon closing of the transaction, which is expected to take place in the second quarter of 2021, the combined company will be listed on the Nasdaq under the new ticker symbol “QSI”.
Founded in 2013 by scientist and entrepreneur Dr. Jonathan Rothberg – who will serve as Executive Chairman of the combined company – Quantum-SI is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to sequence proteins, and digitize proteomic research in order to advance drug discovery and ultimately diagnostics beyond what has been possible with DNA sequencing.
Separately, Mintz recently advised Butterfly Network, Inc. (NYSE: BFLY), an innovative digital health company also founded by Dr. Rothberg, in its $1.5 billion merger with Longview Acquisition Corp. (NYSE: LGVW), a SPAC sponsored by Glenview Capital Management, LLC, which was completed earlier this week.
The Mintz team advising Quantum-SI is led by Managing Member of the Boston Office and Chair of the firm’s Corporate, Tax, Private Client & Immigration Division Michael Fantozzi, Member and Chair of the firm’s Israel Practice Ran Zioni, and Member John Condon.
Mintz is a pioneering firm in the SPAC space and continues its leadership roles in life sciences and sustainability in the growing SPAC market. Having handled the first-ever New York Stock Exchange SPAC transaction, the firm’s interdisciplinary team draws from decades of experience guiding clients in a broad spectrum of industries through the intricacies of SPAC financings. Notably, the firm has handled over 45 SPAC and reverse merger transactions and worked on high-end SPACs for $1 billion plus value companies. Please click here to learn more about Mintz’s SPAC Practice.